Cash Flow Statement

Amortizatization of Intangibles Asset Writedowns and Impairment Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Free Cash Flow Gains from Investment Securities Gains from Sales and Divestitures Net Cash Flow Net Income Non-cash Items Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Lyell Immunopharma (LYEL) Change in Accured Expenses: 2020-2025